Clinical Trial Update: An Open-Label, Extension Study Evaluating the Safety, Toleration, and Efficacy of Sildenafil in Women With Sexual Arousal Disorder [Phase 2]

View source ↗

Summary

Phase 2 open-label extension evaluating safety, tolerability, and efficacy of sildenafil in women with sexual arousal disorder. Completed study.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sexual Arousal Disorder
• Sexual Dysfunctions Psychological

Drugs mentioned

• SILDENAFIL (SILDENAFIL)

Snippet

Sponsor: Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | Conditions: Sexual Dysfunctions, Psychological, Sexual Arousal Disorder | Phase 2 | Status: COMPLETED